Health Care Services

Jefferies & Company has lowered the price target on Lincare Holdings (NASDAQ: LNCR) from $29 to $25 and maintains its Hold rating.

Oppenheimer has lowered the price target on Lincare Holdings (NASDAQ: LNCR) from $32 to $27 and maintains its Perform rating.

Laboratory Corp. of America Holdings (NYSE: LH) announces its next round of earnings this Thursday, October 20, 2011. Here is Benzinga's everything-that-matters guide for this Thursday's third quarter earnings announcement. Earnings and Revenue: Analysts are predicting an EPS reading of $1.60/...

International Business Machines Corp (NYSE: IBM) is projected to report its Q3 EPS at $3.22 on revenue of $26.25 billion. Citigroup Inc (NYSE: C) is estimated to report its Q3 earnings at $0.83 per share on revenue of $19.27 billion. Wells Fargo & Company (NYSE: WFC) is expected to report...

A report from J.P. Morgan reiterates its Neutral rating and $94 price target on LabCorp (NYSE: LH). The report states, “We note that Genzyme pricing appears to have actually increased in 2Q see Table 1. We estimate pricing to decline significantly in 2H11, yet our estimates project ~660 bps...

Below are the top small-cap home health care stocks on the NYSE, the NASDAQ and the AMEX in terms of PEG ratio. Gentiva Health Services Inc (NASDAQ: GTIV) has a PEG ratio of 0.12. GTIV's trailing-twelve-month operating margin is 11.50%. Amedisys Inc (NASDAQ: AMED) has a PEG ratio of 0.52. AMED's...

According to Piper Jaffray, LabCorp of America (NYSE: LH) price target is lowered to $102. Piper Jaffray said that it believes utilization and volume concerns have weighed on shares of LH heading into the Q3 print on Thursday, October 20. “Maintain Overweight rating and lowering price target to $...

Piper Jaffray has lowered the price target on LabCorp of America (NYSE: LH) from $112 to $102 and maintains its Overweight rating.

Laboratory Corporation of America® Holdings (NYSE: LH) today announced that LabCorp is extending until 5:00 p.m., New York City time, on November 4, 2011 LabCorp's previously announced cash tender offer for all outstanding shares of the common stock of Orchid Cellmark Inc. (NASDAQ: ORCH). On May...

Laboratory Corporation of America® Holdings (NYSE: LH) announced today that its Zero Coupon Convertible Subordinated Notes due 2021 may be converted as set forth below. The Zero Coupon Notes are convertible into cash and Common Stock of LabCorp, if any, subject to the terms of the Zero Coupon...

This is your Benzinga news summary and traders' summary for Monday, October 3, 2011, covering headlines from the day and Monday's after-hours session. Today in the domestic after-hours session, U.S equity indices trended lower. At last check, the Dow Jones Industrial Average is down by about 258...

Laboratory Corporation of America (NYSE: LH) announced today the nationwide availability of a new FDA-approved companion diagnostic for lung cancer patients. “The recent approval of XALKORI for NSCLC and its companion test demonstrates how laboratory diagnostics will play an even larger role in...

Shares of Lincare Holdings (NASDAQ: LNCR) are higher on the session by 0.10%, currently trading at $20.81. The stock has been moving largely lower over the past three months and is currently trading below the 50-day moving average. Options traders are focusing on puts today. A short while ago the...

Below are the top small-cap home health care stocks on the NYSE and the NASDAQ in terms of operating margin. The trailing-twelve-month operating margin at Lincare Holdings Inc (NASDAQ: LNCR) is 19.34%. LNCR's PEG ratio is 0.70. The trailing-twelve-month operating margin at Almost Family Inc (...

Laboratory Corporation of America® Holdings (NYSE: LH) announced today that for the period of September 12, 2011 to March 11, 2012, its Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon Notes) will, subject to the terms of the Zero Coupon Notes, accrue contingent cash interest at a...